Trial Profile

Functional C1-INH levels to inform treatment decisions for long-term prophylaxis with plasma-derived C1-INH in patients with C1-INH-HAE, including dose escalation of intravenous C1-INH and switching to subcutaneous C1-INH

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Mar 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Complement C1 inhibitor protein (Primary) ; Complement C1 inhibitor protein (Primary)
Indications Hereditary angioedema
Focus Therapeutic Use

18 Mar 2019 New trial record
25 Feb 2019 Results presented at the 2019 Annual Meeting of the American Academy of Allergy, Asthma and Immunology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com